Medicare's Hidden Costs: Part B Jumps While Part D Tricks You in 2026

The conventional wisdom that Medicare costs remain relatively stable is about to be challenged for millions of seniors. For 2026, the standard monthly premium for Medicare Part B, which covers doctor visits and outpatient services, is slated to increase to $202.90

Centers for Medicare & Medicaid Services (CMS) Reports Finalizing 2027 Medicare Advantage and Part D Payment Policies Saying it Strengthens Accountability and Long-Term Sustainability https://t.co/3nqV9lpVUS

— SIERRA SUN TIMES link

. This represents a notable jump from previous years, demanding a closer look at household budgets. While this increase is finalized, the picture for Medicare Part D prescription drug plans is more complex. Although average premiums are projected to decrease, this doesn't automatically translate to lower out-of-pocket costs for everyone, especially those with high-cost medications. The Centers for Medicare & Medicaid Services (CMS) has finalized policies for both Medicare Advantage and Part D programs, aiming for 'long-term sustainability'

Today, CMS released the Calendar Year 2027 Medicare Advantage (MA) and Part D Rate Announcement to improve payment accuracy and competition across both programs. The finalized policies also advance CMS’ vision of a sustainable and stable MA program that offers high-quality…

— CMSGov link

, but this often means shifting costs or introducing new administrative hurdles. Beneficiaries must actively compare plans, as advertised Part D decreases might mask higher deductibles or copays for specific drugs, a tactic the industry has decided to call 'utilization management,' a phrase that means roughly the same thing as 'no.'

The increase in the standard Part B premium to $202.90 for 2026 isn't solely a reflection of general inflation. While healthcare costs do rise, this adjustment is part of a broader CMS strategy to manage program finances. For many years, a significant portion of the Part B premium increase was linked to covering the costs of beneficiaries who had delayed enrolling in Medicare Part B and faced a late enrollment penalty. However, recent policy adjustments aim to smooth out these increases. Still, the jump is substantial enough to warrant attention, especially for those on fixed incomes. It’s crucial to remember that this is the *standard* premium; some individuals with higher incomes pay an Income-Related Monthly Adjustment Amount (IRMAA) on top of this figure, meaning their Part B costs will rise even more significantly.

The projected decrease in average Medicare Part D premiums for 2026 is a classic example of industry messaging that requires a deep dive. While the headline number might look appealing, it often masks the true cost of prescription drug coverage. Insurers can lower average premiums by adjusting plan designs, which can include increasing deductibles, raising copayments for preferred or non-preferred drugs, or imposing tighter restrictions on formularies. As Dr. Albert Alan noted, CMS has finalized rules for 2027 that affect Medicare Advantage and Part D plans

$UNH $CLOV $HUM $ALHC Today CMS dropped its final rule for how Medicare Advantage and Part D drug plans will work starting in contract year 2027, and there are some meaningful takeaways for anyone holding shares in companies like UnitedHealth, Humana, or Clover Health. The…

— Albert Alan, MD link

, and these changes can influence how much you ultimately pay. Beneficiaries must not only look at the monthly premium but also at the maximum out-of-pocket cost, the deductible amount, and whether their specific medications are covered at a reasonable tier. The industry's push for 'utilization management' is a key driver here, often leading to more hurdles before a prescription is filled.

The finalized payment policies for Medicare Advantage (MA) and Part D in 2027, which include an average increase of 2.48% for MA payments, signal a financially healthy environment for the private companies administering these plans [c2, c3]. This is good news for shareholders of companies like UnitedHealth, Humana, and Oscar Health [c3, c4]. However, for beneficiaries, it underscores the complex interplay between government policy, insurer profitability, and individual costs. CMS states these policies aim to 'improve payment accuracy and competition'

Today, CMS released the Calendar Year 2027 Medicare Advantage (MA) and Part D Rate Announcement to improve payment accuracy and competition across both programs. The finalized policies also advance CMS’ vision of a sustainable and stable MA program that offers high-quality…

— CMSGov link

, but the reality is that higher payments to insurers don't automatically translate into lower costs or better benefits for seniors. Instead, it often means more marketing efforts and plan options that can be bewildering, requiring meticulous comparison shopping each year to ensure you're not overpaying for coverage that doesn't meet your needs.